Mitesh

Currently all branded and generically written prescriptions for Rivaroxaban tablets are reimbursed in line with NHS list prices of the brand originator Xarelto®. However, licensed generic Rivaroxaban tablets have been available in the market for several months following the patent expiry of Xarelto®. Consequently, selling prices of generic Rivaroxaban tablets have fallen sharply when compared [...]

The post Rivaroxaban tablets – changes to reimbursement from September 2024 appeared first on Community Pharmacy England.

Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Drug alert number: EL (24)A/35 MDR number: MDR 113-05/24 Date issued: 08 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Company name: Accord-UK Ltd Product name: Trandolapril 0.5mg [...]

The post MHRA Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Cefalexin 500mg tablets. MSN/2024/083 Tier 2 – medium impact Date of issue: 6th August 2024 Cefalexin 500mg tablets are out of stock until mid-September 2024. Cefalexin 500mg capsules remain available and can support an uplift in demand. Alternative cefalexin preparations remain [...]

The post Medicine Supply Notification: Cefalexin 500mg tablets appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ramipril 2.5mg tablets. MSN/2024/082 Tier 2 – medium impact Date of issue: 6th August 2024 Ramipril 2.5mg tablets are anticipated to be out of stock from mid-August until late-October 2024. Ramipril 2.5mg capsules remain available and can support a full uplift [...]

The post Medicine Supply Notification: Ramipril 2.5mg tablets appeared first on Community Pharmacy England.

In response to a significant ongoing disruption to the supply of Cefalexin 500mg tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 6 August 2024, SSP072 provides that for every Cefalexin 500mg tablet originally prescribed one Cefalexin 500mg capsule must be supplied. SSP072, authorised by the Secretary [...]

The post New SSP issued for Cefalexin 500mg tablets (SSP072) appeared first on Community Pharmacy England.